Search PubMed⌕ Search

Biomedical subjects

M I Marks

Publications and source records attributed to M I Marks.

At least 217 records · Page 12Linked to original sources
PubMed1968

Wolman's disease.

Explore the source record for details and available documents.

Adrenal Glands↗
PubMedDate not supplied

Lethal Haemophilus influenzae type b infection in mice.

Previous animal models of invasive Haemophilus influenzae type b (HITB) infection are characterized by a low mortality rate. We produced a highly lethal infection in CF1 mice using mouse passage, mucin, and hemoglobin to enhance infectivity. Infection by the intraperitoneal route was followed by progressive peritonitis and bacteremia with subsequent HITB infection of the brain and meninges, and death. Death occurred between eight and 72 hours after infection and was associated with 10(6) to 10(9) HITB per ml of blood and with 10(2) to 10(5) HITB per g of brain. Mucin-hemoglobin did not augment HITB growth, but impaired macrophage adherence to glass in vitro, without decreasing cellular viability. In vivo, mucin-hemoglobin decreased the rate of disappearance of 51Cr-labelled HITB from the blood by impairment of hepatic clearance. This technically simple and inexpensive model is useful for the study of HITB infections in which bacterial multiplication, invasion and host lethality are desired features.

Animals↗
PubMedDate not supplied

Clinical significance of Staphylococcus aureus in cystic fibrosis.

Staphylococcus aureus is usually the first bacterial pathogen detected in the respiratory secretions of patients with cystic fibrosis. This review briefly examines the characteristics of this host-parasite relationship in terms of current knowledge about the toxicity of the organism, mechanisms of respiratory tract injury, therapy and prevention. Recent evidence indicates that viral infection plays a role in the initial damage of the respiratory epithelial cells and staphylococcal colonization ensues. Affinity of staphylococcus for cystic fibrosis mucus, mucociliary abnormalities and unknown factors contribute to persistent colonization with this organism causing progressive pulmonary damage and possibly influencing Pseudomonas infection. Most of the evidence today indicates that aggressive antibiotic management directed against S. aureus is warranted in all stages of bronchopulmonary infection in cystic fibrosis. Future efforts to prevent colonization and the toxic and immunopathic consequences of staphylococcal infection are also important. One study is in progress that examines antibiotic prevention in the early stages of cystic fibrosis. Future investigations need to address other strategies including vaccines, antitoxins, anti-inflammatory agents, immunomodulators, and antibiotic regimens.

Anti-Bacterial Agents↗
PubMedDate not supplied

New agents in diarrhea.

Explore the source record for details and available documents.

Anti-Bacterial Agents↗